Article metrics

Download PDFPDF

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study

 

Online download statistics by month:

Online download statistics by month: April 2020 to September 2022

AbstractFullPdf
Apr 202014321423569
May 2020691682294
Jun 2020251240130
Jul 202012111984
Aug 202012912779
Sep 2020143133121
Oct 202020219895
Nov 202021020699
Dec 202013513167
Jan 202115014285
Feb 202120019776
Mar 202115315162
Apr 202112912261
May 202119518578
Jun 202111911347
Jul 202115214774
Aug 2021207203103
Sep 2021184172111
Oct 2021216194127
Nov 202115514783
Dec 202113713249
Jan 202212311550
Feb 202214114159
Mar 202215614762
Apr 202215615498
May 202215014963
Jun 202214413648
Jul 202212011741
Aug 202213211938
Sep 202214413847
Total657763803000